Peter J Rossi

Summary

Affiliation: Emory University School of Medicine
Country: USA

Publications

  1. ncbi request reprint A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone
    Michael A Papagikos
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA
    Am J Clin Oncol 30:199-204. 2007
  2. ncbi request reprint Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer
    Peter J Rossi
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1030, USA
    Urology 67:349-53. 2006
  3. ncbi request reprint Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis
    Peter J Rossi
    Department of Radiation Oncology, Emory University School of Medicine, 1365 Clifton Rd, NE, Atlanta, GA 30322, USA
    Int J Radiat Oncol Biol Phys 70:134-8. 2008
  4. doi request reprint Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer
    Peter J Rossi
    Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA
    Radiother Oncol 90:353-8. 2009
  5. doi request reprint A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age
    Breanne E Terakedis
    Department of Radiation Oncology, Emory University, Atlanta, GA, USA
    Am J Clin Oncol 33:619-23. 2010
  6. ncbi request reprint Therapeutic options for a rising PSA after radical prostatectomy
    Bradley C Carthon
    Department of Hematology Oncology, Emory University, Atlanta, GA 30322, USA
    Can J Urol 20:6748-55. 2013
  7. doi request reprint Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone
    Peter J Rossi
    Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA
    Brachytherapy 7:286-9. 2008
  8. ncbi request reprint Salvage therapy for locally recurrent prostate cancer after radiation
    David M Marcus
    Department of Radiation Oncolgy, Emory University, Atlanta, Georgia, USA
    Can J Urol 19:6534-41. 2012
  9. ncbi request reprint Applying population dynamics modeling to patients with lymph node positive prostate cancer
    Peter A S Johnstone
    Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    J Urol 178:1952-5; discussion 1955-6. 2007
  10. doi request reprint Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis
    Ashesh B Jani
    Department of Radiation Oncology, Emory University, Atlanta, Georgia 30322, USA
    Am J Clin Oncol 33:168-72. 2010

Collaborators

Detail Information

Publications25

  1. ncbi request reprint A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone
    Michael A Papagikos
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA
    Am J Clin Oncol 30:199-204. 2007
    ..The objective of this study was to describe a simple model that predicts freedom from biochemical recurrence (FFBR) in men with prostate cancer after treatment with low-dose rate prostate brachytherapy (LDRPB) alone...
  2. ncbi request reprint Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer
    Peter J Rossi
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1030, USA
    Urology 67:349-53. 2006
    ..The PPBs has been associated with FFBR in men treated with radical prostatectomy and external beam radiotherapy for prostate cancer...
  3. ncbi request reprint Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis
    Peter J Rossi
    Department of Radiation Oncology, Emory University School of Medicine, 1365 Clifton Rd, NE, Atlanta, GA 30322, USA
    Int J Radiat Oncol Biol Phys 70:134-8. 2008
    ..To assess the role of radiotherapy (RT) in women with Stage IIIC endometrial cancer...
  4. doi request reprint Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer
    Peter J Rossi
    Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA
    Radiother Oncol 90:353-8. 2009
    ..The purpose of this report is to evaluate the movement of the planning target volume (PTV) in relation to the pelvic lymph nodes (PLNs) during treatment of high-risk prostate cancer...
  5. doi request reprint A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age
    Breanne E Terakedis
    Department of Radiation Oncology, Emory University, Atlanta, GA, USA
    Am J Clin Oncol 33:619-23. 2010
    ....
  6. ncbi request reprint Therapeutic options for a rising PSA after radical prostatectomy
    Bradley C Carthon
    Department of Hematology Oncology, Emory University, Atlanta, GA 30322, USA
    Can J Urol 20:6748-55. 2013
    ..In this review, we detail existing treatment algorithms for this group of patients as well as future therapies that show great promise...
  7. doi request reprint Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone
    Peter J Rossi
    Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA
    Brachytherapy 7:286-9. 2008
    ..This report examines the relationship between pretreatment prostate-specific antigen (PSA) velocity (PSAV) and freedom from biochemical recurrence (FFBR) in men with prostate cancer treated with low-dose-rate prostate brachytherapy (LDRPB)...
  8. ncbi request reprint Salvage therapy for locally recurrent prostate cancer after radiation
    David M Marcus
    Department of Radiation Oncolgy, Emory University, Atlanta, Georgia, USA
    Can J Urol 19:6534-41. 2012
    ..To date, there is little data describing outcomes and toxicity associated with each of these salvage modalities...
  9. ncbi request reprint Applying population dynamics modeling to patients with lymph node positive prostate cancer
    Peter A S Johnstone
    Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    J Urol 178:1952-5; discussion 1955-6. 2007
    ..Patients with prostate cancer and positive lymph nodes are often considered to be doomed to distant failure. We applied these models to that population to examine whether those data support this presumption...
  10. doi request reprint Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis
    Ashesh B Jani
    Department of Radiation Oncology, Emory University, Atlanta, Georgia 30322, USA
    Am J Clin Oncol 33:168-72. 2010
    ..Our objectives were to analyze time trends in the use of surgery and RT and type of RT (external beam RT [EBRT], brachytherapy [Brachy] or combination EBRT + Brachy [Combo])...
  11. doi request reprint Stage IV prostate cancer: survival differences in clinical T4, nodal and metastatic disease
    Wayland Hsiao
    Department of Urology, Emory University School of Medicine, Atlanta, Georgia
    J Urol 184:512-8. 2010
    ..Assignment to stage IV prostate cancer may occur by different modes, namely as T4N0M0 vs N1 vs M1 disease. We hypothesize that patients with clinical T4 disease have better outcomes than those with N1 or M1 disease...
  12. doi request reprint Pelvic shape and prostate motion: implications for target volume design and analysis of acute toxicity
    Ashesh B Jani
    Department of Radiation Oncology, Emory University, Atlanta, GA 30322, USA
    Am J Clin Oncol 32:291-5. 2009
    ..To study the impact of pelvic shape on prostate motion and the implications for radiotherapy target design and treatment outcomes...
  13. doi request reprint Lymphadenectomy for patients with cervical cancer: is it of value?
    Peter J Rossi
    Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA
    J Surg Oncol 100:404-6. 2009
    ..The purpose of this Surveillance Epidemiology and End Results (SEER) analysis was to assess the value of lymphadenectomy (LND) in patients with cervical cancer...
  14. doi request reprint High-dose radiotherapy with or without androgen deprivation therapy for intermediate-risk prostate cancer: cancer control and toxicity outcomes
    Scott Edelman
    Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GA, USA
    Int J Radiat Oncol Biol Phys 83:1473-9. 2012
    ..To evaluate the impact of short-course androgen deprivation therapy (ADT) on cancer control outcomes and toxicity in intermediate-risk prostate cancer treated with dose-escalated external beam radiotherapy (high-dose radiotherapy [HDRT])...
  15. doi request reprint Toxicity analysis of dose escalation from 75.6 gy to 81.0 gy in prostate cancer
    Natalie Xu
    Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA
    Am J Clin Oncol 34:11-5. 2011
    ..Our objective was to perform a toxicity analysis of a minor dose escalation (from 75.6 to 81.0 Gy) within this "high-dose" range...
  16. doi request reprint Treatment efficiency of volumetric modulated arc therapy in comparison with intensity-modulated radiotherapy in the treatment of prostate cancer
    William A Hall
    Department of Radiation Oncology and the Winship Cancer Institute, Emory University, Atlanta, Georgia 30322, USA
    J Am Coll Radiol 10:128-34. 2013
    ..The aim of this study was to test this hypothesis by measuring the average patient in-room time with VMAT versus dynamic multileaf collimator (DMLC) IMRT...
  17. ncbi request reprint A review of low-dose-rate prostate brachytherapy--techniques and outcomes
    David M Marcus
    Department of Radiation Oncology, Emory University School of Medicine, GA 30322, USA
    J Natl Med Assoc 102:500-10. 2010
    ..As research in prostate brachytherapy continues, it is likely that this modality will play an increasingly important role in the treatment of early-stage prostate cancer patients in the future...
  18. doi request reprint Influence of vascular comorbidities and race on erectile dysfunction after prostate cancer radiotherapy
    Yuefeng Wang
    Department of Radiation Oncology, Emory University, Atlanta, GA 30322, USA
    J Sex Med 10:2108-14. 2013
    ..However, no data are yet available for the effects of VC on ED incidence after prostate cancer radiotherapy (XRT)...
  19. pmc Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT
    David M Schuster
    Department of Radiology, Emory University Hospital, 1364 Clifton Rd, Atlanta, GA 30322, USA
    Radiology 259:852-61. 2011
    ....
  20. doi request reprint Performance evaluation of Calypso 4D localization and kilovoltage image guidance systems for interfraction motion management of prostate patients
    Tomi Ogunleye
    Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA
    ScientificWorldJournal 9:449-58. 2009
    ..Implications for Calypso's role as a QA tool are discussed...
  21. doi request reprint Observations on prostate intrafraction motion and the effect of reduced treatment time using volumetric modulated arc therapy
    Jay Shelton
    Department of Radiation Oncology, Emory University, Atlanta, Georgia Electronic address
    Pract Radiat Oncol 1:243-50. 2011
    ..We hypothesize that treatment duration is a controllable factor associated with intrafraction target motion...
  22. ncbi request reprint The impact of multiparametric pelvic magnetic resonance imaging on risk stratification in patients with localized prostate cancer
    David M Marcus
    Department of Radiation Oncology, Emory University, Atlanta, GA Winship Cancer Institute, Emory University, Atlanta, GA Electronic address
    Urology 84:132-7. 2014
    ..To determine the impact of multiparametric magnetic resonance imaging (MP-MRI) of the prostate on established risk stratification criteria in patients with clinically localized adenocarcinoma of the prostate (ACP)...
  23. ncbi request reprint Publication rate of abstracts from the annual ASTRO meeting: comparison with other organizations
    Michael A Papagikos
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
    J Am Coll Radiol 2:72-5. 2005
    ..The purpose of this study was to determine the publication rate of abstracts accepted for oral presentation at ASTRO's 1999, 2000, and 2001 annual meetings...
  24. ncbi request reprint Dosimetric quantifiers for low-dose-rate prostate brachytherapy: is V(100) superior to D(90)?
    Michael A Papagikos
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Brachytherapy 4:252-8. 2005
    ....
  25. ncbi request reprint Redo infrainguinal bypass: factors predicting patency and limb salvage
    Peter J Rossi
    Department of Surgery, Section of Vascular Surgery, The University of Chicago, Chicago, IL, USA
    Ann Vasc Surg 17:492-502. 2003
    ..Nonetheless, patency and limb salvage rates justify an attempt at revascularization after failed primary bypass...